Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 872170, 5 pages
Research Article

Pathological Feature and Immunoprofile of Cystitis Glandularis Accompanied with Upper Urinary Tract Obstruction

1Department of Urology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai 200090, China
2Department of Urology, Huadong Hospital Affiliated with Fudan University, Shanghai 200040, China

Received 19 March 2014; Revised 28 April 2014; Accepted 28 April 2014; Published 29 May 2014

Academic Editor: Christian Schwentner

Copyright © 2014 Aihua Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. H. Li, S. K. Liu, H. H. Lu et al., “Clinical character of cystitis glandularis accompanied with upper urinary tract obstruction,” Canadian Urological Association Journal, vol. 7, pp. E708–E710, 2013. View at Google Scholar
  2. A. H. Li, H. H. Lu, S. K. Liu, F. Zhang, X. Qian, and H. Wang, “Clinical investigation on the relationship between upper urinary tract obstruction and the accompanied chronic cystitis,” Current Urology, vol. 2, no. 3, pp. 142–145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. He, Z. G. Zhang, W. Ding et al., “Study of thee xpression of CK20 and Ki67 on cystitis glandularis of the urinary bladder,” Clinical Medicine, vol. 27, pp. 79–80, 2007. View at Google Scholar
  4. Z.-Q. Chen, Z.-F. Wei, Z.-Q. Ye, and W.-M. Yang, “Expression of cancer-related indices in different types of cystitis glangularis and clinical significance thereof,” National Medical Journal of China, vol. 85, no. 26, pp. 1842–1844, 2005. View at Google Scholar · View at Scopus
  5. Z. X. Li, R. Feng, D. Wu et al., “The p53 and Ki-67 expression and its clinical significance in patients with cystitis glandularis,” Journal of Clinical Urology, vol. 26, pp. 506–509, 2011. View at Google Scholar
  6. J. F. Huang and J. Chen, “Expresion of Rasp21 in cystitis glurclolaris and bladder prinary tumor and its significance,” Acta Medicinae Sinica, vol. 20, pp. 1195–1197, 2007. View at Google Scholar
  7. W. G. Ma, P. J. Li, J. Y. Lu et al., “Expressions of CD44V6 and MMP-9 in recurrent and non-recurrent cystitis glandularis,” Chinese General Practice, vol. 13, pp. 2694–2696, 2010. View at Google Scholar
  8. S. T. Xiao, S. W. Zhou, W. Guan et al., “MUC1 expression in cystitis glandularis and adenocarcinoma,” Journal of Guangxi Medical University, vol. 23, pp. 890–893, 2006. View at Google Scholar
  9. P. Jiang, B. Liu, X. Zheng et al., “Expression of COX-2 in cystitis glandularis and its implication to relapse,” Journal of Chinese General Practice, vol. 24, pp. 601–602, 2009. View at Google Scholar
  10. M.-T. Sung, A. Lopez-Beltran, J. N. Eble et al., “Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder,” Modern Pathology, vol. 19, no. 11, pp. 1395–1401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. L. J. Velickovic, V. Katic, T. Hattori, R. Kushima, G. Marjanovic, and V. Stefanovic, “Differences in the expression of mucins in various forms of cystitis glandularis,” Pathology Research and Practice, vol. 203, no. 9, pp. 653–658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. X. Chen, N. Deng, X. Chen et al., “A novel molecular grading model: Ki67 and VEGF in non-invasive urothelial bladder cancer,” Asian Pacific Journal of Cancer Prevention, vol. 13, pp. 2229–2234, 2012. View at Google Scholar
  13. A. Stepan, C. Simionescu, C. Mǎrgǎritescu, and R. Ciurea, “P16, c-erbB2 and Ki67 immunoexpression in urothelial carcinomas of the bladder,” Romanian Journal of Morphology and Embryology, vol. 52, no. 2, pp. 653–658, 2011. View at Google Scholar · View at Scopus
  14. V. Margulis, S. F. Shariat, R. Ashfaq, A. I. Sagalowsky, and Y. Lotan, “Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease,” Clinical Cancer Research, vol. 12, no. 24, pp. 7369–7373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. D. C. Ogata, C. A. P. R. Marcondes, F. F. Tuon, W. F. S. Busato Júnior, G. Cavalli, and L. E. A. Czeczko, “Superficial papillary urothelial neoplasms of the bladder (PTA EPT1): correlation of expression of p53, KI-67 and CK20 with histologic grade, recurrence and tumor progression,” Revista do Colegio Brasileiro de Cirurgioes, vol. 39, no. 5, pp. 394–400, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Lopez-Beltran, R. J. Luque, J. Alvarez-Kindelan et al., “Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters,” The American Journal of Clinical Pathology, vol. 122, no. 3, pp. 444–452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. X. G. del Muro, E. Condom, F. Vigués et al., “p53 and p21 expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach,” Cancer, vol. 100, no. 9, pp. 1859–1867, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. H. E. Hassan, A. A. B. Mohamed, A. O. Bakhiet, and H. G. Ahmed, “Immunohistochemical expression of COX2 and iNOS in bladder cancer and its association with urinary schistosomiasis among Sudanese patients,” Infectious Agents and Cancer, vol. 8, article 9, pp. 2–6, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Li, T. Yang, L. Li et al., “Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma,” Colloids and Surfaces B, vol. 37, no. 1-2, pp. 15–19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Wadhwa, A. K. Goswami, K. Joshi, and S. K. Sharma, “Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder,” International Urology and Nephrology, vol. 37, no. 1, pp. 47–53, 2005. View at Publisher · View at Google Scholar · View at Scopus